At what age does Medicaid stop covering routine screening mammograms for average-risk women?

Medicaid Coverage for Screening Mammography: No Universal Age Cutoff

Medicaid does not have a federally mandated upper age limit for stopping screening mammography coverage—this decision is made by individual states, though most align with clinical guidelines recommending continuation until at least age 75 years for women in good health.

Understanding the Coverage Landscape

The question asks specifically about Medicaid policy, but it's critical to understand that Medicaid coverage decisions are made at the state level, not federally mandated 1. Unlike Medicare, which has standardized coverage policies set by the Centers for Medicare & Medicaid Services, each state's Medicaid program determines its own screening mammography coverage parameters 1, 2.

Clinical Guidelines That Inform State Medicaid Policies

While Medicaid coverage varies by state, most programs reference major clinical guidelines when establishing their policies. Here's what the evidence-based guidelines recommend:

Age 75 as a Key Decision Point

Multiple major guidelines recommend continuing screening mammography until at least age 75 years 3:

• American College of Obstetricians and Gynecologists (ACOG): Women at average risk should continue screening mammography until at least age 75 years 3

• Beyond age 75: The decision should be based on shared decision-making informed by the woman's health status and longevity, not age alone 3

Life Expectancy as the Critical Factor

The American Cancer Society and American College of Physicians recommend continuing screening as long as a woman has good overall health and a life expectancy of at least 10 years 4, 3. This is based on the fact that it takes approximately 11 years on average before one death from breast cancer is prevented per 1,000 women screened 3.

USPSTF Position on Older Women

The U.S. Preventive Services Task Force (USPSTF) states that current evidence is insufficient to assess benefits and harms of screening mammography in women 75 years or older 5. This "I statement" (insufficient evidence) means they cannot make a recommendation either for or against screening in this age group.

Practical Implications for Medicaid Beneficiaries

State-Level Variation

Research shows significant variation in how states implement mammography screening incentives and coverage under Section 1115 waivers 2. Some states have created incentive programs that don't align with evidence-based guidelines, with starting ages and frequencies that conflict with USPSTF recommendations 2.

Common Pitfalls to Avoid

1. Don't assume federal uniformity: Coverage policies differ substantially between states
2. Don't use age 65 as a cutoff: This Medicare eligibility age is not a clinical screening endpoint
3. Don't ignore functional status: A healthy 80-year-old with 10+ years life expectancy may benefit more than a 70-year-old with multiple comorbidities

Assessing Life Expectancy

When determining whether to continue screening beyond age 75:

• Women aged 70-75 with no comorbidities: Average life expectancy is 15-19 years 3
• Women aged 70-75 with serious comorbidities: Average life expectancy is approximately 9-11 years 3
• Use mortality indices incorporating age, comorbidities, and functional status 4

Algorithmic Approach for Clinical Decision-Making

For Medicaid beneficiaries under age 75:

• Continue biennial screening mammography (most guidelines support this) 3, 5

For Medicaid beneficiaries age 75 and older:

1. Assess overall health status and comorbid conditions
2. Estimate life expectancy using validated tools
3. If life expectancy ≥10 years AND patient values screening benefits → continue screening
4. If life expectancy <10 years OR significant competing mortality risks → discontinue screening
5. Engage in shared decision-making discussing the 11-year lag time to mortality benefit 3

The Bottom Line for Practice

There is no specific age at which Medicaid "stops" covering screening mammograms. State Medicaid programs typically cover screening mammography for eligible women without an arbitrary upper age cutoff, though coverage details vary by state. The clinical decision to stop screening should be based on individual health status and life expectancy rather than age alone, with age 75 serving as a reasonable inflection point for more careful individualized assessment 3.